|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.398 SEK | +1.45% |
|
+8.37% | -29.04% |
| 07-08 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| 06-30 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
EPS & Dividend: IRLAB Therapeutics AB
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.922 | 1 | -2.188 | -3.429 | -1.603 | -1.642 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 42.000 | 44.000 | 38.300 | 7.500 | 10.750 | 1.970 |
| Nbr of stocks (in thousands) | 51,748 | 51,748 | 51,868 | 51,868 | 51,868 | 84,938 |
| Announcement Date | 4/15/21 | 4/8/22 | 4/29/24 | 4/29/24 | 4/25/25 | 4/29/26 |
1SEK in Million2SEK
Estimates
Past dividends: IRLAB Therapeutics AB
| 2026-06-08 | Ex-dividend date - 0.97854 SEK | 00:00 |
Upcoming Events: IRLAB Therapeutics AB
| 2026-08-26 | Earnings release | Q2 2026 | |
| 2026-11-13 | Earnings release | Q3 2026 | |
| 2027-02-11 | Earnings release | Annual 2026 | Day |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.56% | 0.62% | 35.49x | 21.56x | 12.92x | |
| 2.06% | 2.16% | 27.65x | 6.95x | 6.35x | |
| 2.74% | 2.89% | 30.17x | 1346.43x | 7.39x | |
| 2.98% | 3.06% | 17.88x | 6.64x | 4.44x | |
| 1.86% | 1.97% | 22.38x | 5.23x | 4.7x | |
| 2.86% | 2.95% | 21.53x | 6.42x | 5.52x | |
| 3.55% | 3.45% | 14.08x | 6.2x | 5.27x | |
| 2.77% | 2.93% | 23.79x | 18.25x | 6.31x | |
| 2.41% | 2.49% | -47.8x | 8.43x | 5.8x | |
| Average | 2.42% | 2.5% | 16.13x | 158.46x | 6.52x | |
| Weighted average by Cap. | 1.97% | 2.05% | 24.02x | 175.06x | 7.99x |
Annual Profit -
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
